Europe considers relaxing DTP law

Share this article:

European Union regulators are weighing relaxing a prohibition on direct communication with patients by drug companies. 

European Medicines Agency head Peter Arlett told Bloomberg the European Commission “will revise the proposals to clarify and harmonize the rules in what companies can and can't say to patients.”

There has long been talk of liberalization of consumer promotion regs in Europe, though US-style ads are not in the cards. However, regulators have in the past indicated openness to letting drug makers put more information online and communicate with patients through opt-in direct mail and emails.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters